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Abstract 
Diguanylate cyclases (DGC) and phosphodiesterases (PDE) respectively synthesize and hydrolyze the 
secondary messenger cyclic dimeric GMP (c-di-GMP), and both activities are often found in a single 
protein. Intracellular c-di-GMP levels in turn regulate bacterial motility, virulence and biofilm 
formation. We report the first structure of a tandem DGC–PDE fragment, in which the catalytic 
domains are shown to be active. Two phosphodiesterase states are distinguished by active site 
formation. The structures, in the presence or absence of c-di-GMP, suggest that dimerization and 
binding pocket formation are linked, with dimerization being required for catalytic activity. An 
understanding of PDE activation is important, as biofilm dispersal via c-di-GMP hydrolysis has 
therapeutic effects on chronic infections. 
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Abbreviations  
c-di-GMP, cyclic dimeric guanosine monophosphate; DGC, diguanylate cyclase; GTP, guanosine 
triphosphate; MorA, motility regulator A; PDB, protein data bank; PDE, phosphodiesterase; pGpG, 
phosphate guanosine phosphate guanosine 
 
1. Introduction 
Biofilms are the major form of bacterial organisation and are a common problem in chronic infections 
(1, 2). For the bacterium Pseudomonas aeruginosa, chronic infection and biofilm formation is the 
main cause of mortality for sufferers of cystic fibrosis (3). Biofilms display an increased persistence 
and tolerance to antibiotics (4). Physiologically, biofilm formation is associated with high levels of 
the secondary messenger c-di-GMP (5, 6), which is synthesised by diguanylate cyclases (DGC) from 
two GTP molecules (7). Reduction in c-di-GMP levels (8) can be achieved by NO stimulation, 
leading to biofilm dispersal, thereby allowing for the treatment of infectious diseases (9).  
Biofilm dispersion is linked to c-di-GMP hydrolysis by two types of phosphodiesterases (PDE) (10) 
with either an EAL (11) or a HD-GYP (12) motif. The two classes differ with respect to their 
hydrolysis products. HD-GYP domains hydrolyse c-di-GMP into two GMP molecules and have been 
shown to utilise trinuclear iron binding (13). EAL domains, however, hydrolyse c-di-GMP to the 
linear di-nucleotide 5’-pGpG and additionally require a dimerisation event for PDE activation (14). 
EAL domains have been identified to contain two key surface helices providing a binding groove for 
an antiparallel dimer formation (15, 16). In addition to the EAL motif, a second conserved 
DDFGTG(YSS) sequence motif coordinates the Mg2+ ions required for activity (14). Domains with a 
degenerate DDFGTG and EAL motif are catalytically inactive and instead function as c-di-GMP 
sensor proteins (17). 
EAL phosphodiesterase domains often occur in tandem with a diguanylate cyclase domain, in a single 
protein (18). A structure of these dual domain proteins is known from the DGC-PDE c-di-GMP 
sensor protein LapD (19). Conversion to the sensor is explained by a lack of the conserved EAL and 
DDFGTG motifs required for PDE activity. The determination of the structure of LapD provides 
insight into the regulation of nucleotide binding, as the isolated EAL domain can bind c-di-GMP, but 
in the tandem domain structure the nucleotide-binding pocket is obstructed. For proteins with dual 
activity, the underlying question is how the two opposing activities of cyclase and phosphodiesterase 
are controlled. 
We have studied the tandem domain protein MorA (Motility Regulator A), conserved across 
Pseudomonas species (20). Additional to PDE and DGC domains, the cytosolic segment contains four 
PAS sensory domains (Per-Arnt-Sim homology) (21). The protein is localised to the membrane by 
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two N-terminal transmembrane helices and can affect bacterial motility (20). MorA has been linked to 
fimbriae and flagella formation, prerequisites for biofilm formation and dispersal respectively (22, 
23). The protein is also reported to control the timing of flagella development and regulate sensory 
chemotaxis pathways (20). The C-terminal PDE domain of MorA shows intact DDFGTG and EAL 
motifs, indicative of phosphodiesterase activity. 
Here, we report the catalytic activity and structure of the tandem DGC-PDE fragment from MorA in 
the absence and presence of c-di-GMP and two structures of the isolated PDE in absence of 
nucleotide, but distinguished by dimerisation. Our data describe two states of the PDE nucleotide-
binding pocket. The four structures suggest that dimerisation is involved in the formation of the 
nucleotide-binding pocket and catalytic activity. Understanding of PDE activation is highly sought 
after as biofilm dispersal results in bacteria becoming susceptible to antibiotics. 
 
2. Materials and methods 
2.1. Molecular biology and protein purification 
Genomic DNA of P. aeruginosa PAO1 was isolated using the DNeasy blood and tissue kit (Qiagen). 
MorA gene PA4601 was amplified by PCR using Phusion Polymerase (Finnzymes); PCR fragments 
were restriction digested and inserted into the expression vector pET-28a (Novagen). The following 
fragments were cloned with N-terminal fusion tags: DGC978-1144, PDE145-1409 and tandem DGC-PDE978-
1409
. The D1310N/D1311N point mutations were introduced into tandem DGC-PDE978-1409 using the 
Lightning QuikChange kit (Invitrogen). 
For recombinant expression of all proteins, BL21 DE3 E. coli competent cultures were grown in LB 
medium and induced by 1 mM isopropyl-beta-D-thiogalactopyranoside (Melford) at an optical density 
OD600 of 0.6. The cultures were collected after 20 h growth at 18 °C by centrifugation. Cells from 2 
litre cultures were resuspended in 50 ml 50 mM HEPES buffered at pH 7.5 with 300 mM NaCl, 5% 
glycerol, lysed by sonication, and centrifuged at 16,000 rpm for 40 min (Avanti centrifuge, Beckman 
JA25.50 rotor). The supernatant was loaded onto 4 ml Ni-NTA resin (Qiagen), equilibrated with 
buffer A (50 mM HEPES buffered at pH 7.5 with 300 mM NaCl, 2 mM MgCl2, 5% glycerol, 2 mM 
β-mercaptoethanol and 20 mM imidazole), followed by washes with buffer A containing 80 mM 
imidazole and elution using buffer A containing 300 mM imidazole. Following concentration over 
spin concentrators (Generon), the eluate was loaded onto an S75 16/600 size exclusion column (GE) 
equilibrated in 50 mM HEPES buffered at pH 7.5 with 300 mM NaCl, 2 mM MgCl2 and 2 mM β-
mercaptoethanol. Fractions containing the desired protein, confirmed by SDS-PAGE, were pooled 
and concentrated using spin concentrators (Generon). 
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2.2 Enzymatic assay.  
Activity of MorA fragments was determined by an enzyme assay followed by HPLC analysis of 
nucleotides, adapted from (24). Enzymes were used at a concentration of 40 µM; these were mixed 
with 0.1 mM GTP (Biolog) in 50 mM HEPES buffered at pH 7.5, with 300 mM NaCl, 2 mM MgCl2 
and 2 mM β-mercaptoethanol to 200 µl and incubated at room temperature for 1 hour. Samples were 
then run on a combination of a C4 and a C18 RPC column (Vydac), using a Shimadzu HPLC system, 
in buffer A (100 mM KPO4 buffered at pH 6) with an elution gradient of 15 min into buffer B (70% 
buffer A with 30% methanol). Absorbance at 254 nm was used for detection. The system was 
calibrated using GTP (Sigma), 5’-pGpG (Biolog) and c-di-GMP, prepared by enzymatic synthesis 
from GTP, using purified YdeH as described in (25).  
2.3. Bis-4pNPP analysis  
PDE activity was measured in 1 ml total volume containing 0.4 mg/ml protein, 5 mM bis-4pNPP 
(Sigma) and 50 mM Tris pH 9.2 with 5 mM MgCl2 and 50 mM NaCl. The reaction was carried out at 
37 °C. After 180 min the absorbance of the hydrolysed product was measured at 405 nm using a 
nanodrop spectrophotometer (Thermo Scientific). Controls contained heat inactivated proteins (100 
°C, 5 min). 
2.4. Structure determination and analysis  
Purified proteins were crystallised in sitting drop 96-well plates using a Gryphon nanodrop dispenser 
(Art Robbins Instruments). Crystal hit optimisation was carried out using a Minstrel DT alchemist 
(Rigaku). Data were collected at the Southampton Diffraction Centre, the Diamond Light Source 
(DLS, Oxford) and the European Synchrotron Radiation Facility (ESRF, Grenoble). Data reduction, 
molecular replacement and refinement were carried out with CCP4 (26) and Phenix (27, 28); models 
were built using Coot (29) and automated water structure building in ArpWarp (30) (Table 1). 
Dyndom was used to determine hinge regions (31). PISA was used to calculate protein-protein 
interfaces (32). Pymol was used to create figures (Schrödinger). 
DGC-PDE978-1409 D1310N/D1311N mutant (PDB 4RNF): crystallised at 21°C and a concentration of 
26 mg/ml in 0.12 M Morpheus alcohols, 0.1 M Buffer System 1, 30% EDO P8K (Molecular 
Dimensions). Data were collected at DLS I03 to a resolution of 2.85 Å. The structure was solved by 
molecular replacement with dimeric PDE1145-1409 (this study), and the GGDEF domain from 
Methylococcus capsulatus (PDB 3ICL, (33)).  
DGC-PDE978-1409 c-di-GMP complex (PDB 4RNH): crystallised at 21°C and a concentration of 20 
mg/ml and 2 molar excess of GTP (Sigma) in 0.2 M sodium thiocyanate, 20% w/v PEG 3350. Data 
were collected at DLS I04 to a resolution of 2.45 Å. The structure was solved by molecular 
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replacement using the DGC-PDE978-1409 D1310N/D1311N mutant (this study). Instead of GTP, we 
obtained c-di-GMP bound to the active site of the PDE in this crystal form.  
Dimeric PDE1145-1409 (PDB 4RNI): crystallised at 21°C and a concentration of 10 mg/ml and 3 molar 
excess of 5’-pGpG (Biolog) in 0.1 M Morpheus Buffer System 3, 0.1 M amino acids, 30% GOL P4K 
(Molecular Dimensions). Data were collected at DLS I04 to a resolution of 2.17 Å. The structure was 
solved by molecular replacement, using the Thiobacillus denitrificans phosphodiesterase (PDB 3N3T, 
(34)). 5’-pGpG was not visible in the final structure but required for crystallisation.  
Monomeric PDE1145-1409 (PDB 4RNJ): crystallised at 21°C and a concentration of 12 mg/ml in 0.1 M 
Morpheus Buffer System 1, 0.09 M NPS, 30% EDO P8K (Molecular Dimensions). Data were 
collected at ESRF ID14-1 to a resolution of 2.32 Å. The structure was solved by molecular 
replacement with dimeric PDE1145-1409 (this study). 
 
3. Results ands Discussion 
3.1. Activity assay 
To confirm that MorA is a suitable system to study bi-functional c-di-GMP regulation, we first 
ensured that MorA has diguanylate cyclase and phosphodiesterase activities. Our analysis is based on 
RPC-HPLC separation of nucleotide products. When an isolated DGC978-1144 fragment was incubated 
with GTP, a retention product at 10 minutes is observed that corresponds to the c-di-GMP standard 
(Fig. 1A). This indicates MorA has diguanylate cyclase activity. 
To study the bi-functional enzyme, we incubated the MorA fragment containing both DGC and PDE 
domains (DGC-PDE978-1409) with GTP. HPLC analysis of reaction products showed a peak with a 
decreased retention time, compared with c-di-GMP that corresponds to the 5’-pGpG standard (Fig. 
1A). Since no c-di-GMP was added in this experiment this indicates MorA’s DGC produced c-di-
GMP, which we observed as a small peak, consistent with the standard. However, the majority is 
converted to the linear nucleotide indicating MorA also has phosphodiesterase activity. The PDE 
containing fragments were further tested with the generic PDE substrate bis (p-nitrophenyl) phosphate 
(Table S1), confirming activity in the PDE domain. 
To corroborate the DGC activity in the tandem DGC-PDE fragment, we mutated the PDE domain to 
obtain a catalytically inactive variant. To do this, the DDFGTG sequence motif was replaced with 
NNFGTG (D1310N and D1311N). The two aspartates that were replaced coordinate the Mg2+ ions 
required for activity (14). HPLC analysis of reaction products after incubation with GTP showed a 
peak that corresponds to the c-di-GMP standard (Fig. 1A). Thus, the mutant DGC-PDE fragment 
retained DGC activity but was unable to produce 5’-pGpG, indicating the mutation renders the PDE 
inactive (Table S1).  
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The activity assays showed that MorA’s DGC and PDE domains could synthesise and hydrolyse c-di-
GMP respectively. Since MorA has both, DGC and PDE catalytic activity, it is implicit that MorA 
should have mechanisms to control these opposing activities. Likely mechanisms are either interaction 
of PDE and DGC domains, or oligomerisation. Indeed, dimerisation of DGC domains is required for 
cyclase activity, as each monomer contributes one nucleotide to the product, and dimerisation of PDE 
domains is known to influence phosphodiesterase activity (15, 16). We therefore investigated the 
protein fragments for oligomerisation and initiated structural studies. 
 
3.2 Nucleotide free state of MorA DGC-PDE 
To determine the nucleotide free state of the tandem fragment we used the MorA DGC-PDE978-1409 
D1310 and D1311 mutant; experiments to acquire a nucleotide free structure of the wild type tandem 
fragment yielded non-diffracting crystals. The overall structure of MorA’s DGC-PDE978-1409 mutant is 
comprised of an arrangement that separates the DGC and PDE domains into an open conformation 
(Fig. 1B,C). A 31Å long helix (named H-helix, see section 3.4.), involving 19 amino acid residues 
(A1145 to L1167), links the DGC and PDE domains. The DGC of MorA adopts the archetypical 
GGDEF domain fold that consists of five alpha helices surrounding a five stranded beta sheet 
(αβααββαβαβ) (Fig. 1B) (35). The DGC is nucleotide free and the nucleotide recognising helix α2 is 
disordered. The conformation seen does not preclude DGC dimerisation. MorA’s PDE forms the 
canonical (β/α)8 barrel in which the first beta strand is reversed (11), with respect to classic TIM 
topology (Fig. 1C) (36). The open conformation is stabilised by direct contact between residues 
K1076 and E1213 located on the DGC-α4 and PDE-α4’ helices (SFig. 1). In the open conformation, 
both the PDE and DGC active sites are accessible.  
An interesting feature of the MorA DGC-PDE978-1409 mutant is the local structure around helix PDE-
α5. The PDE-α5 helix in MorA is extended and consists of residues G1315 to Q1324, resulting in the 
removal of the DDFGTG motif from the active site, which would be required for Mg2+ coordination 
and activity. A nucleotide free structure of the wild type PDE was determined using the isolated 
fragment, PDE1145-1409. Intriguingly, this monomeric PDE1145-1409 structure shows the same features as 
the MorA DGC-PDE978-1409 mutant with an extended PDE-α5 helix in a Mg2+ free state and the 
DDFGTG motif removed from the active site (Fig. 2A). Since formation of the helix PDE-α5 
extension removes catalytic residues from the active site, we have named this helix repressor helix (R 
helix). It is known that dimerisation regulates PDE activity and hence we went on to characterise a 
structure of a PDE dimer to investigate the nature of this structural rearrangement. 
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3.3. PDE dimerisation influences the conformation of the R helix 
To promote dimer formation, we crystallised the isolated PDE1145-1409 domain of MorA in the presence 
of 5’-pGpG. Crystallisation yielded a nucleotide-free dimer with contacts around the α5-helix (R 
helix) and the α6 helix (Fig. 2B). PDE domain dimers have been previously identified (Table S2) (15-
17, 19, 37, 38). PDE dimerisation involving PDE-α6 and the R helix has implications for active site 
formation. The PDE dimer contact between residues Y1316 and S1317 stabilises the loop formed by 
residues G1315 to S1318 and thus stabilises a state in which the R helix is shortened (L1319 to 
Q1324) (Fig. 2A). The shorter conformation of the R helix is consistent with the previously solved 
catalytically active c-di-GMP bound structure from T. denitrificans phosphodiesterase (PDB 3N3T). 
An extended R helix (G1315 to Q1324), as seen in the nucleotide-free structures, is not compatible 
with dimer formation, as it would lead to clashes around the dimer interface and not allow residues 
Y1316 and S1317 of the 1310DDFGTGYSS1318 motif to contribute to dimer formation. Conservation of 
the YS residues is, therefore, explained by their involvement in PDE dimerisation (Fig. 2). 
Dimerisation around the R helix, therefore, stabilises the DDFGTGYSS motif into an extended loop 
conformation. However, no nucleotide or Mg2+ are present in the active site. The dimeric PDE1145-1409 
structure is presumably observed post-hydrolysis, where the product 5’-pGpG has left the binding site. 
To understand the significance of the different R helix conformations, we wanted to study the 
nucleotide-bound state of the PDE within MorA. 
 
3.4. Nucleotide bound state of MorA DGC-PDE 
To obtain the c-di-GMP complex, we had to mix the tandem DGC-PDE978-1409 wild type fragment 
with excess GTP immediately before crystallisation. Binding of c-di-GMP into the native PDE active 
site of MorA results in PDE dimerisation of the tandem fragment (Fig. 3A). The orientation of PDE 
dimer is similar to the one observed within the isolated PDE1145-1409 structure in the presence of 5’-
pGpG (Fig. 2) and (Table S2). The DGC domains in this dimer do not interaction with one another 
(Fig. 3B).  
In the nucleotide-bound form the R helix adopts the shorter conformation (L1319 to Q1324), 
compared to the wild type nucleotide free monomeric PDE (G1315 to Q1324) (Fig. 3C). The shorter 
conformation of the R helix allows the extended loop conformation of the DDFGTG motif to 
contribute to active site formation, where residues D1310 and D1311 of the DDFGTG motif, along 
with residue E1189 of the EAL motif coordinate two Mg2+ ions (Fig. 3C and SFig. 2). Interpretation 
of this c-di-GMP complex is that of a Michaelis complex that has yet to undergo activation (8), as the 
tandem DGC-PDE is able to hydrolyse c-di-GMP to 5’pGpG (Fig. 1A).  
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Comparison of the PDE domains presented here allows for an assignment of two distinct states (Fig. 
3C and Fig. 4). The nucleotide-free structures show the repressed state with an incomplete active site, 
characterised by an extension of the R helix (PDE-α5), removes the DDFGTG motif from the active 
site and results in the loss of Mg2+ binding. This state is different to the dimeric state of the PDE1145-
1409
 and c-di-GMP bound DGC-PDE, where a shorter R helix is formed. Interactions at the dimeric 
interface stabilise the DDFGTGYSS motif into an extended loop conformation that allows the 
aspartates of the DDFGTG motif to bind Mg2+ and contribute to active site formation. A further 
difference is observed with respect to the residue Tyr1389 that acts as a gate to the active site and is 
involved in base stacking of one of the c-di-GMP guanosine moieties (Fig. 2A and Fig. 3C). 
When the nucleotide-free DGC-PDE mutant and the nucleotide-bound DGC-PDE structures are 
compared a slight rotation of twenty degrees is observed between the DGC and PDE domains (SFig. 
4). The rotation suggests that a hinge, located on the H helix (hinge), links the DGC and PDE 
domains. This hinge is located on the EAL domain side. Other orientations of the two domains might 
be possible. 
 
4. Conclusion 
The tandem DGC-PDE MorA structure represents the first structure determined for a dual active DGC 
and PDE enzyme. From comparison of the four structures determined, we provide evidence of a 
conformational change occurring around the R helix (PDE-α5) of the PDE domain that can repress 
catalytic activity by removing the DDFGTG motif form the active site. We show how the conserved 
YS residues of the DDFGTGYSS motif are involved in PDE dimerisation to promote structural 
changes that enable the enzyme to bind c-di-GMP. Dimer interactions favour a shortened R helix and 
allow the two catalytic aspartates of the DDFGTGYSS motif to enter the active site. Regulation of 
PDE activity must now be put in the context of protein dimerisation. The challenge is to understand 
the influence of MorA domains outside the DGC-PDE, such as the transmembrane localisation or the 
PAS domains. A deciphering of the further regulatory mechanisms within MorA and other tandem 
DGC-PDE proteins is essential for the development of drugs that tackle biofilm formation and to 
understand the regulation of bacterial virulence.  
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Figure 1. Enzymatic activity and crystal structure of the nucleotide free state of MorA tandem 
DGC-PDE. (A) HPLC analysis of nucleotide loading states after incubation with GTP; DGC, 
DGC978-1144; DGC-PDE, DGC-PDE978-1409; DGC-PDE mutant, DGC-PDE978-1409 D1310N/D1311N; 
standards as indicated; x-axis in minutes, y-axis AU at λ=254. (B) MorA DGC-PDE978-1409 
D1310N/D1311N structure with the DGC domain in orange, the GGDEF sequence motif is 
highlighted in green. Alpha helices and beta sheets are labelled in accordance to classical TIM barrels. 
The α2 helix is disordered (dashed line). The H helix (cyan) links the DGC domain to the PDE 
domain (grey). (C) MorA DGC-PDE978-1409 D1310N/D1311N structure in different orientation to (B) 
shows the PDE domain in yellow.. The active site DDFGTG motif and the α5 helix or R helix are 
highlighted in blue, the α6 helix is shown in purple. The H helix (cyan) links the PDE domain to the 
DGC domain (grey). 
 
Figure 2. MorA PDE dimer formation and conformational changes of the R helix. (A) Overlay of 
monomeric PDE1145-1409 structure (marine blue) with the dimeric PDE1145-1409  (green). The two 
structures differ in the orientation and length of the R helix (PDE-α5). The R helix is extended in the 
monomeric PDE structure (G1315-Q1324, marine blue) but shorter in the dimeric PDE structure 
(L1319-Q1324, green) resulting in different conformations of the DDFGTGYSS motif. Y1389 acts as 
a gate to the active site and is seen in two different side chain rotamer conformations. (B) The dimer 
interface is formed through reciprocal contact of Y1316 and S1317 from monomer A (green) and a 
symmetry molecule (-X, -Y +1/2, Z +1/2) (grey). These two residues are part of the DDFGTGYSS 
motif. The dimeric structure is characterised by a short R helix (α5, L1319-Q1324). 
 
Figure 3. Crystal structure of the dimeric form of MorA DGC-PDE. (A) Structure of the DGC- 
PDE978-1409 c-di-GMP complex forms a PDE dimer, similar to the isolated PDE1145-1409dimer (Fig. 2 
and Table S2). Monomer A is coloured light-blue, the symmetry mate (X-Y, -Y, -Z+2/3) is shown in 
light-orange. The DGC domains are not interacting in this dimer. (B) Fig 3A rotated by 30 degrees. 
(C) Overlay of the two different PDE states determined: monomeric PDE1144-1409 in the nucleotide free 
repressed state (marine blue) and the nucleotide-bound DGC-PDE978-1409 structure in the dimeric state 
(light-blue). The Repressor helix, PDE-α5, changes in orientation and length, affecting the structure 
of the catalytic DDFGTG motif. In the repressed state the aspartates of the DDFGTGYSS motif are 
removed from the active site, in the dimeric state the motif forms an extended loop that allows the 
residues to engage Mg2+ and substrate. 
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Figure 4. The role of amino acids in the DDFGTGYSS motif. The side chains of two aspartate 
residues (DD) are involved in Mg2+ coordination and the side chains of the tyrosine/serine residues 
(YS) are involved in PDE dimerisation. 
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Table 1. X-ray data collection and refinement statistics 
aValues in parentheses are for the highest-resolution bin 
  
 DGC-PDE978-1409 
Mutant D1310/1311N  
DGC-PDE978-1409 
Dimer C-di-GMP Complex  
PDE1145-1409 
Apo-Monomer 
PDE1145-1409 
Apo-Dimer 
Accession code 4RNF 4RNH 4RNJ 4RNI 
Space Group 
Cell a, b, c (Å) 
 
Angles α, β, γ (°) 
P1 
40.7, 47.4, 60.0 
82.15, 71.63, 70.66 
 
P3121 
81.3, 81.3, 128.0 
90, 90, 120 
P212121 
52.0, 79.8, 138.5 
90, 90, 90 
P21212 
35.6, 94.5, 154.6 
90, 90, 90 
Resolution (Å) a 28.46-2.85  
(3.26-2.85) 
61.7-2.45  
(2.52-2.45) 
48.75-2.32  
(2.4-2.32) 
77.35-2.17 
(2.23-2.17) 
Rmerge (%) a 17.4 (59.1) 10.7 (74.6) 7.2 (67.8) 11.0 (78.8) 
I/σ(I) a 7.4 (2.4) 14.5 (2.6) 13.87 (1.8) 18.3 (3.9) 
No. Unique 
Reflections  
9235 18546 25720 28764 
Completeness (%) a 98.5 (98.0) 100 (99.5) 99.7 (98.4) 100 (99.8) 
Redundancy a 2.8 (2.7) 8.1 (6.3) 4.28 (3.69) 13.3 (13.4) 
Refinement     
Rwork/Rfree (%) 23.1/27.7 18.7/24.3 19.8/25.3 18.4/23.5 
No. Protein atoms 
No. Ligand atoms /ion 
No. Waters 
3332 
- 
12 
3525 
(c-di-GMP/Mg2+) 68/4 
140 
3996 
- 
121 
3961 
- 
156 
Protein Bfactor (Å2) 
Ligand/ion Bfactor (Å2) 
Water Bfactor (Å2) 
36.3 
- 
52.6 
45.3 
(c-di-GMP/Mg2+) 54.2/50.4 
45.1 
42.6 
- 
28.9 
36.9 
- 
35 
Bond lengths rmsd (Å) 
Bond angles rmsd (°) 
0.014 
1.370 
0.006 
0.815 
0.013 
1.431 
0.002 
0.860 
Ramachandran (%) 
Preferred Regions 
Allowed Regions 
Outliers 
 
95.96 
3.80 
0.24 
 
97.58 
2.42 
0 
 
98.61 
1.39 
0 
 
98.41 
1.59 
0 
Closest contact Monomer A and 
symmetry A (X-1, Y+1, 
Z) ∆G of -5 kJ/mol with 
a surface area of 
1002.7 Å2. 
Monomer A and symmetry 
A (X–Y, -Y, -Z-1/3) ∆G of -
14.5 kJ/mol with a surface 
area of 1631.6 Å2. 
Monomer A and B 
∆G of -4 kJ/mol with 
a surface area of 
776.5 Å2. 
Monomer A and B 
∆G of -11.6 kJ/mol 
with a surface area 
of 1070.8 Å2. 
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Highlights 
• A helix separates diguanylate cyclase and phosphodiesterase in tandem active MorA 
• The conserved sequence motif DDFGTGYSS changes structure in response to dimerisation 
• The DDFGTGYSS sequence contains the YS dimerisation motif 
• The phosphodiesterase helix α5 (R helix) removes the motif form the active site 
• The DDFGTGYSS sequence contains the DD motif for magnesium coordination  
 
 
